Zhuoming Li

2.2k total citations · 1 hit paper
42 papers, 1.5k citations indexed

About

Zhuoming Li is a scholar working on Molecular Biology, Geriatrics and Gerontology and Oncology. According to data from OpenAlex, Zhuoming Li has authored 42 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 10 papers in Geriatrics and Gerontology and 6 papers in Oncology. Recurrent topics in Zhuoming Li's work include Sirtuins and Resveratrol in Medicine (10 papers), Signaling Pathways in Disease (6 papers) and Mitochondrial Function and Pathology (5 papers). Zhuoming Li is often cited by papers focused on Sirtuins and Resveratrol in Medicine (10 papers), Signaling Pathways in Disease (6 papers) and Mitochondrial Function and Pathology (5 papers). Zhuoming Li collaborates with scholars based in China, United States and Australia. Zhuoming Li's co-authors include Peiqing Liu, Peiqing Liu, Suowen Xu, Peter J. Little, Jianping Weng, Xueying Zheng, Hong Li, Alastair G. Stewart, Scott J. Cameron and Jihong Han and has published in prestigious journals such as Scientific Reports, FEBS Letters and The Journal of Physical Chemistry C.

In The Last Decade

Zhuoming Li

41 papers receiving 1.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies

2021 686 citations Suowen Xu, Iqra Ilyas et al. Pharmacological Reviews profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zhuoming Li China	19	710	274	250	243	231	42	1.5k
Peili Bu China	26	787 1.1×	375 1.4×	273 1.1×	113 0.5×	346 1.5×	64	1.7k
Stephan Winnik Switzerland	17	542 0.8×	362 1.3×	220 0.9×	122 0.5×	396 1.7×	46	1.7k
Xing Chang China	26	1.3k 1.9×	368 1.3×	529 2.1×	158 0.7×	174 0.8×	56	2.2k
Litai Jin China	23	1.0k 1.4×	168 0.6×	230 0.9×	109 0.4×	105 0.5×	81	1.8k
Brian B. Ratliff United States	23	794 1.1×	146 0.5×	185 0.7×	218 0.9×	110 0.5×	43	2.0k
Ae Sin Lee South Korea	21	456 0.6×	114 0.4×	181 0.7×	145 0.6×	194 0.8×	36	1.4k
Kenji Kasuno Japan	16	785 1.1×	127 0.5×	276 1.1×	140 0.6×	435 1.9×	44	1.8k
Alexander Akhmedov Switzerland	25	686 1.0×	480 1.8×	217 0.9×	472 1.9×	125 0.5×	49	2.0k
Baoxin Liu China	18	368 0.5×	278 1.0×	185 0.7×	104 0.4×	146 0.6×	61	1.1k
Zheng Yang China	28	814 1.1×	659 2.4×	213 0.9×	134 0.6×	79 0.3×	51	1.7k

Countries citing papers authored by Zhuoming Li

Since Specialization

Citations

This map shows the geographic impact of Zhuoming Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhuoming Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhuoming Li more than expected).

Fields of papers citing papers by Zhuoming Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhuoming Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhuoming Li. The network helps show where Zhuoming Li may publish in the future.

Co-authorship network of co-authors of Zhuoming Li

This figure shows the co-authorship network connecting the top 25 collaborators of Zhuoming Li. A scholar is included among the top collaborators of Zhuoming Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhuoming Li. Zhuoming Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Minghui, Haiming Xiao, Shanshan Li, et al.. (2024). Cinnamaldehyde activates AMPK/PGC-1α pathway via targeting GRK2 to ameliorate heart failure. Phytomedicine. 133. 155894–155894. 9 indexed citations

Li, Senlin, Jing Lü, Cui Liu, et al.. (2024). Palmitic Acid Accelerates Endothelial Cell Injury and Cardiovascular Dysfunction via Palmitoylation of PKM2. Advanced Science. 12(5). e2412895–e2412895. 16 indexed citations

Wang, Jiaojiao, Yuanyuan Li, Man Zhao, et al.. (2024). Cytosolic DNA initiates a vicious circle of aging-related endothelial inflammation and mitochondrial dysfunction via STING: the inhibitory effect of Cilostazol. Acta Pharmacologica Sinica. 45(9). 1879–1897. 6 indexed citations

Xu, Zhanchi, Minghui Li, Haiming Xiao, et al.. (2024). Xinbao Pill ameliorates heart failure via regulating the SGLT1/AMPK/PPARα axis to improve myocardial fatty acid energy metabolism. Chinese Medicine. 19(1). 82–82. 7 indexed citations

Wang, Minghui, Yan-qing Ding, Yuehuai Hu, et al.. (2023). SIRT3 improved peroxisomes-mitochondria interplay and prevented cardiac hypertrophy via preserving PEX5 expression. Redox Biology. 62. 102652–102652. 18 indexed citations

Tong, Lin, Wanqi Yang, Wenwei Luo, et al.. (2022). Disturbance of Fatty Acid Metabolism Promoted Vascular Endothelial Cell Senescence via Acetyl‐CoA‐Induced Protein Acetylation Modification. Oxidative Medicine and Cellular Longevity. 2022(1). 1198607–1198607. 27 indexed citations

Li, Zhuoming, et al.. (2022). Multi-agent reinforcement learning for fleet management: a survey. 145–145. 2 indexed citations

Xu, Suowen, Iqra Ilyas, Peter J. Little, et al.. (2021). Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies. Pharmacological Reviews. 73(3). 924–967. 686 indexed citations breakdown →

Lü, Jing, Suowen Xu, Yuqing Huo, et al.. (2021). Sorting nexin 3 induces heart failure via promoting retromer-dependent nuclear trafficking of STAT3. Cell Death and Differentiation. 28(10). 2871–2887. 22 indexed citations

10.

Wang, Panxia, Zhenzhen Li, Zhenzhen Li, et al.. (2020). Histone H4R3 symmetric di-methylation by Prmt5 protects against cardiac hypertrophy via regulation of Filip1L/β-catenin. Pharmacological Research. 161. 105104–105104. 23 indexed citations

11.

Tong, Lin, Wenwei Luo, Ziqing Li, et al.. (2020). Rhamnocitrin extracted from Nervilia fordii inhibited vascular endothelial activation via miR-185/STIM-1/SOCE/NFATc3. Phytomedicine. 79. 153350–153350. 17 indexed citations

12.

Liu, Rong, Panxia Wang, Jingyan Li, et al.. (2020). PRMT5 Prevents Cardiomyocyte Hypertrophy via Symmetric Dimethylating HoxA9 and Repressing HoxA9 Expression. Frontiers in Pharmacology. 11. 600627–600627. 13 indexed citations

13.

Li, Zhenzhen, Xiaoying Zhang, Zhen Guo, et al.. (2019). SIRT6 Suppresses NFATc4 Expression and Activation in Cardiomyocyte Hypertrophy. Frontiers in Pharmacology. 9. 1519–1519. 31 indexed citations

14.

Liu, Xiaoyue, et al.. (2018). Application of Bionics of Tiger Beetle to Aerodynamic Optimization of MIRA Fastback Model. DEStech Transactions on Computer Science and Engineering. 3 indexed citations

15.

He, Ping, Zhuoming Li, Zhongbao Yue, et al.. (2017). SIRT3 prevents angiotensin II-induced renal tubular epithelial-mesenchymal transition by ameliorating oxidative stress and mitochondrial dysfunction. Molecular and Cellular Endocrinology. 460. 1–13. 38 indexed citations

16.

Lü, Jing, Duanping Sun, Zhiping Liu, et al.. (2016). SIRT6 suppresses isoproterenol-induced cardiac hypertrophy through activation of autophagy. Translational research. 172. 96–112.e6. 84 indexed citations

17.

Lü, Jing, Duanping Sun, Shuya Sun, et al.. (2016). The poly(ADP-ribosyl)ation of FoxO3 mediated by PARP1 participates in isoproterenol-induced cardiac hypertrophy. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1863(12). 3027–3039. 23 indexed citations

18.

Li, Jingyan, Hui Gao, Junying Huang, et al.. (2016). PKCζ interacts with STAT3 and promotes its activation in cardiomyocyte hypertrophy. Journal of Pharmacological Sciences. 132(1). 15–23. 15 indexed citations

19.

Feng, Xiaojun, Xiaoying Zhang, Xiaoyang Huang, et al.. (2016). SIRT6 suppresses phenylephrine-induced cardiomyocyte hypertrophy though inhibiting p300. Journal of Pharmacological Sciences. 132(1). 31–40. 40 indexed citations

20.

Liu, Zhiping, Jiaojiao Wang, Xiaoyang Huang, Zhuoming Li, & Peiqing Liu. (2016). Deletion of sirtuin 6 accelerates endothelial dysfunction and atherosclerosis in apolipoprotein E-deficient mice. Translational research. 172. 18–29.e2. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact